Pharma Mar SAU (PHMR)

Madrid
Currency in EUR
79.350
-1.200(-1.49%)
Closed

Pharma Mar (PHMR) Latest Cash Flow Statement

Advanced Cash Flow Statement
Collapse All
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-24.21278.9425.6838.32-13.45
Cash from Operations Growth
Net Income
Depreciation & Amortisation, Total
Amortisation of Deferred Charges, Total
Other Non-Cash Items, Total
Change in Net Operating Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-43.88%+1,252.22%-90.79%+49.24%-135.09%
aa.aaaa.aaaa.aaaa.aaaa.aa-11.38137.2692.8649.361.14
aa.aaaa.aaaa.aaaa.aaaa.aa4.34.334.564.894.72
aa.aaaa.aaaa.aaaa.aaaa.aa3.732.881.031.011.03
aa.aaaa.aaaa.aaaa.aaaa.aa-7.286.53-11.3611.2914.58
aa.aaaa.aaaa.aaaa.aaaa.aa-13.58127.94-61.41-28.22-34.92
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa32.07-119.0118.4710.88-43.05
Cash from Investing Growth
Capital Expenditure
Sale of Property, Plant, and Equipment
Cash Acquisitions
Divestitures
Other Investing Activities
aa.aaaa.aaaa.aaaa.aaaa.aa+41.02%-471.11%+115.52%-41.11%-495.73%
aa.aaaa.aaaa.aaaa.aaaa.aa-3.96-3-7.8-8.85-15.96
aa.aaaa.aaaa.aaaa.aaaa.aa0.03--0.01-
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa33.39----
aa.aaaa.aaaa.aaaa.aaaa.aa2.62-116.0126.2819.72-27.09
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-12.97-73.82-27.42-13.37-32.14
Cash from Financing Growth
Total Debt Issued
Short Term Debt Issued, Total
Long-Term Debt Issued, Total
Total Debt Repaid
Short Term Debt Repaid, Total
Long-Term Debt Repaid, Total
Issuance of Common Stock
Repurchase of Common Stock
Issuance of Preferred Stock
Repurchase of Preferred Stock
Common & Preferred Stock Dividends Paid
Special Dividend Paid
Other Financing Activities
Foreign Exchange Rate Adjustments
Miscellaneous Cash Flow Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-78.67%-469.34%+62.86%+51.23%-140.37%
aa.aaaa.aaaa.aaaa.aaaa.aa4.790.835.831.546.39
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa4.790.835.831.546.39
aa.aaaa.aaaa.aaaa.aaaa.aa-18.84-32.37-15.27-10.2-7.54
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa-18.84-32.37-15.27-10.2-7.54
aa.aaaa.aaaa.aaaa.aaaa.aa8.5630.3733.5557.2318.61
aa.aaaa.aaaa.aaaa.aaaa.aa-7.47-63.71-40.66-50.18-37.9
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa--8.82-10.87-11.76-11.69
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa-0.01-0.12---
aa.aaaa.aaaa.aaaa.aaaa.aa--7.540.40.64-1.16
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa-5.1178.5717.1436.47-89.79
Beginning Cash Balance
Ending Cash Balance
Levered Free Cash Flow
Levered Free Cash Flow Growth
Free Cash Flow Yield
aa.aaaa.aaaa.aaaa.aaaa.aa22.7517.6496.21113.35149.81
aa.aaaa.aaaa.aaaa.aaaa.aa17.6496.21113.35149.8160.02
aa.aaaa.aaaa.aaaa.aaaa.aa-4.65128.414.7533.11-12.59
aa.aaaa.aaaa.aaaa.aaaa.aa+33.06%+2,858.59%-96.3%+596.58%-138.01%
aa.aaaa.aaaa.aaaa.aaaa.aa-3.57%21.25%1.73%2.54%-4.00%
* In Millions of EUR (except for per share items)